Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' EICHELBAUM M' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 117 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Brinkmann, U; Roots, I; Eichelbaum, M
      Pharmacogenetics of the human drug-transporter gene MDR1: impact of polymorphisms on pharmacotherapy

      DRUG DISCOVERY TODAY
    2. Eichelbaum, M; Burk, O
      CYP3A genetics in drug metabolism

      NATURE MEDICINE
    3. Zanger, UM; Fischer, J; Raimundo, S; Stuven, T; Evert, BO; Schwab, M; Eichelbaum, M
      Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6

      PHARMACOGENETICS
    4. Long, T; Klein, K; Fischer, J; Nussler, AK; Neuhaus, P; Hofmann, U; Eichelbaum, M; Schwab, M; Zanger, UM
      Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver (vol 11, pg 399, 2001)

      PHARMACOGENETICS
    5. Eichelbaum, M; Evans, W; Yamazoe, Y
      A tribute to Frank Gonzalez

      PHARMACOGENETICS
    6. Lang, T; Klein, K; Fischer, J; Nussler, AK; Neuhaus, P; Hofmann, U; Eichelbaum, M; Schwab, M; Zanger, UM
      Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver

      PHARMACOGENETICS
    7. Hitzl, M; Drescher, S; van der Kuip, H; Schaffeler, E; Fischer, J; Schwab, M; Eichelbaum, M; Fromm, MF
      The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56(+) natural killer cells

      PHARMACOGENETICS
    8. Siegle, I; Fritz, P; Eckhardt, K; Zanger, UM; Eichelbaum, M
      Cellular localization and regional distribution of CYP2D6 mRNA and proteinexpression in human brain

      PHARMACOGENETICS
    9. Griese, EU; Ilett, KF; Kitteringham, NR; Eichelbaum, M; Powell, H; Spargo, RM; LeSouef, PN; Musk, AW; Minchin, RF
      Allele and genotype frequencies of polymorphic cytochromes P4502D6, 2C19 and 2E1 in Aborigines from Western Australia

      PHARMACOGENETICS
    10. Fritz, P; Murdter, TE; Eichelbaum, M; Siegle, I; Weissert, M; Zanger, UM
      Microsomal epoxide hydrolase expression as a predictor of tamoxifen response in primary breast cancer: A retrospective exploratory study with long-term follow-up

      JOURNAL OF CLINICAL ONCOLOGY
    11. Schaeffeler, E; Eichelbaum, M; Brinkmann, U; Penger, A; Asante-Poku, S; Zanger, UM; Schwab, M
      Frequency of C3435T polymorphism of MDR1 gene in African people

      LANCET
    12. Hustert, E; Zibat, A; Presecan-Siedel, E; Eiselt, R; Mueller, R; Fuss, C; Brehm, I; Brinkmann, U; Eichelbaum, M; Wojnowski, L; Burk, O
      Natural protein variants of pregnane X receptor with altered transactivation activity toward CYP3A4

      DRUG METABOLISM AND DISPOSITION
    13. Pauli-Magnus, C; Murdter, T; Godel, A; Mettang, T; Eichelbaum, M; Klotz, U; Fromm, MF
      P-glycoprotein-mediated transport of digitoxin, alpha-methyldigoxin and beta-acetyldigoxin

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    14. Geick, A; Eichelbaum, M; Burk, O
      Nuclear receptor response elements mediate induction of intestinal MDR1 byrifampin

      JOURNAL OF BIOLOGICAL CHEMISTRY
    15. Coller, JK; Fritz, P; Zanger, UM; Siegle, I; Eichelbaum, M; Kroemer, HK; Murdter, TE
      Distribution of microsomal epoxide hydrolase in humans: An immunohistochemical study in normal tissues, and benign and malignant tumours

      HISTOCHEMICAL JOURNAL
    16. Schwab, M; Schaeffeler, E; Marx, C; Zanger, U; Aulitzky, W; Eichelbaum, M
      Shortcoming in the diagnosis of TPMT deficiency in a patient with Crohn's disease using phenotyping only

      GASTROENTEROLOGY
    17. von Richter, O; Greiner, B; Fromm, MF; Fraser, R; Omari, T; Barclay, ML; Dent, J; Somogyi, AA; Eichelbaum, M
      Determination of in vivo absorption, metabolism, and transport of drugs bythe human intestinal wall and liver with a novel perfusion technique

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    18. Busse, D; Fromm, MF; Morike, K; Drescher, S; Kuhlkamp, V; Eichelbaum, M
      Disposition and pharmacologic effects of R/S-verapamil in patients with chronic atrial fibrillation: An investigation comparing single and multiple dosing

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    19. Cascorbi, I; Gerloff, T; Johne, A; Meisel, C; Hoffmeyer, S; Schwab, M; Schaeffeler, E; Eichelbaum, M; Brinkmann, U; Roots, I
      Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    20. Schaeffeler, E; Lang, T; Zanger, UM; Eichelbaum, M; Schwab, M
      High-throughput genotyping of thiopurine S-methyltransferase by denaturingHPLC

      CLINICAL CHEMISTRY
    21. Hofmann, U; Pecia, M; Heinkele, G; Dilger, K; Kroemer, HK; Eichelbaum, M
      Determination of propafenone and its phase I and phase II metabolites in plasma and urine by high-performance liquid chromatography-electrospray ionization mass spectrometry

      JOURNAL OF CHROMATOGRAPHY B
    22. von Richter, O; Eichelbaum, M; Schonberger, F; Hofmann, U
      Rapid and highly sensitive method for the determination of verapamil, [H-2(7)]verapamil and metabolites in biological fluids by liquid chromatography-mass spectrometry

      JOURNAL OF CHROMATOGRAPHY B
    23. Raimundo, S; Fischer, R; Eichelbaum, M; Griese, EU; Schwab, M; Zanger, UM
      Elucidation of the genetic basis of the common 'intermediate metabolizer' phenotype for drug oxidation by CYP2D6

      PHARMACOGENETICS
    24. Schwab, M; Roder, F; Aleker, T; Ammon, S; Thon, KP; Eichelbaum, M; Klotz, U
      Psychotropic drug use, falls and hip fracture in the elderly

      AGING-CLINICAL AND EXPERIMENTAL RESEARCH
    25. Bohnenstengel, F; Friedel, G; Ritter, CA; McClellan, M; Fritz, P; Eichelbaum, M; Linder, A; Toomes, H; Dierkesmann, R; Kroemer, HK
      Variability of cyclophosphamide uptake into human bronchial carcinoma: consequences for local bioactivation

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    26. Gross, AS; Eichelbaum, M; Morike, K; Mikus, G
      Pharmacokinetics and pharmacodynamics of R- and S-gallopamil during multiple dosing

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    27. Dilger, K; Meisel, P; Hofmann, U; Eichelbaum, M
      Disposition of propafenone in a poor metabolizer of CYP2D6 with Gilbert's syndrome

      THERAPEUTIC DRUG MONITORING
    28. Ammon, S; Von Richter, O; Hofmann, U; Thon, KP; Eichelbaum, M; Mikus, G
      In vitro interaction of codeine and diclofenac

      DRUG METABOLISM AND DISPOSITION
    29. Hoffmeyer, S; Burk, O; von Richter, O; Arnold, HP; Brockmoller, J; Johne, A; Cascorbi, I; Gerloff, T; Roots, I; Eichelbaum, M; Brinkmann, U
      Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    30. Pauli-Magnus, C; von Richter, O; Burk, O; Ziegler, A; Mettang, T; Eichelbaum, M; Fromm, MF
      Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    31. Morike, K; Eichelbaum, M
      Principles of drug therapy and basic pharmacokinetic concepts

      INTERNIST
    32. Eckhardt, K; Nevo, I; Levy, R; Mikus, G; Eichelbaum, M; Vogel, Z
      Morphine-related metabolites differentially activate adenylyl cyclase isozymes after acute and chronic administration

      FEBS LETTERS
    33. Fromm, MF; Kauffmann, HM; Fritz, P; Burk, O; Kroemer, HK; Warzok, RW; Eichelbaum, M; Siegmund, W; Schrenk, D
      The effect of rifampin treatment on intestinal expression of human MRP transporters

      AMERICAN JOURNAL OF PATHOLOGY
    34. Hofmann, U; Seefried, S; Schweizer, E; Ebner, T; Mikus, G; Eichelbaum, M
      Highly sensitive gas chromatographic-tandem mass spectrometric method for the determination of morphine and codeine in serum and urine in the femtomolar range

      JOURNAL OF CHROMATOGRAPHY B
    35. Waldegger, S; Niemeyer, G; Morike, K; Wagner, CA; Suessbrich, H; Busch, AE; Lang, F; Eichelbaum, M
      Effect of verapamil enantiomers and metabolites on cardiac K+ channels expressed in Xenopus oocytes

      CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
    36. Dalen, P; Dahl, ML; Eichelbaum, M; Bertilsson, L; Wilkinson, GR
      Disposition of debrisoquine in Caucasians with different CYP2D6-genotypes including those with multiple genes

      PHARMACOGENETICS
    37. Griese, EU; Asante-Poku, S; Ofori-Adjei, D; Mikus, G; Eichelbaum, M
      Analysis of the CYP2D6 gene mutations and their consequences for enzyme function in a West African population

      PHARMACOGENETICS
    38. Dilger, K; Greiner, B; Fromm, MF; Hofmann, U; Kroemer, HK; Eichelbaum, M
      Consequences of rifampicin treatment on propafenone disposition in extensive and poor metabolizers of CYP2D6

      PHARMACOGENETICS
    39. Griese, EU; Lapple, F; Eichelbaum, M
      Detection of CYP2C19 alleles*1,*2 and*3 by multiplex polymerase chain reaction

      PHARMACOGENETICS
    40. Jorge, LF; Eichelbaum, M; Griese, EU; Inaba, T; Arias, TD
      Comparative evolutionary pharmacogenetics of CYP2D6 in Ngawbe and Embera Amerindians of Panama and Colombia: role of selection versus drift in world populations

      PHARMACOGENETICS
    41. Dilger, K; Eckhardt, K; Hofmann, U; Kucher, K; Mikus, G; Eichelbaum, M
      Chronopharmacology of intravenous and oral modified release verapamil

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    42. Fritz, P; Sperker, B; Murdter, TE; Spath, M; Schwarzmann, P; Kroemer, HK; Eichelbaum, M; Kivisto, KT
      Quantitative immunohistochemical analysis of the glutathione S-transferaseGSTM1: in situ phenotyping in archival material

      XENOBIOTICA
    43. Greiner, B; Eichelbaum, M; Fritz, P; Kreichgauer, HP; Von Richter, O; Zundler, J; Kroemer, HK
      The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin

      JOURNAL OF CLINICAL INVESTIGATION
    44. Tugnait, M; Hawes, EM; McKay, G; Eichelbaum, M; Midha, KK
      Characterization of the human hepatic cytochromes P450 involved in the in vitro oxidation of clozapine

      CHEMICO-BIOLOGICAL INTERACTIONS
    45. GRIESE EU; ZANGER UM; BRUDERMANNS U; GAEDIGK A; MIKUS G; MORIKE K; STUVEN T; EICHELBAUM M
      ASSESSMENT OF THE PREDICTIVE POWER OF GENOTYPES FOR THE IN-VIVO CATALYTIC FUNCTION OF CYP2D6 IN A GERMAN POPULATION

      Pharmacogenetics
    46. Busse, D; Busch, FW; Schweizer, E; Bohnenstengel, F; Eichelbaum, M; Fischer, P; Schumacher, K; Aulitzky, WE; Kroemer, HK
      Fractionated administration of high-dose cyclophosphamide: influence on dose-dependent changes in pharmacokinetics and metabolism

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    47. FROMM MF; DILGER K; BUSSE D; KROEMER HK; EICHELBAUM M; KLOTZ U
      GUT WALL METABOLISM OF VERAPAMIL IN OLDER-PEOPLE - EFFECTS OF RIFAMPICIN-MEDIATED ENZYME-INDUCTION

      British journal of clinical pharmacology
    48. ECKHARDT K; LI SX; AMMON S; SCHANZLE G; MIKUS G; EICHELBAUM M
      SAME INCIDENCE OF ADVERSE DRUG EVENTS AFTER CODEINE ADMINISTRATION IRRESPECTIVE OF THE GENETICALLY-DETERMINED DIFFERENCES IN MORPHINE FORMATION

      Pain
    49. SJOQVIST F; EICHELBAUM M; DAHLQVIST R
      DENGLER,HANS,J - IN-MEMORIAM

      European Journal of Clinical Pharmacology
    50. SCHRENK D; BROCKMEIER D; MORIKE K; BOCK KW; EICHELBAUM M
      A DISTRIBUTION STUDY OF CYP1A2 PHENOTYPES AMONG SMOKERS AND NONSMOKERS IN A COHORT OF HEALTHY CAUCASIAN VOLUNTEERS

      European Journal of Clinical Pharmacology
    51. LAEPPLE F; GRIESE EU; ZANGER U; THON KP; EICHELBAUM M
      ANALYSIS OF CYP2C8, CYP2C9, CYP2C18 AND CYP2C19 MESSENGER-RNA EXPRESSION IN HUMAN LIVER, SMALL-INTESTINE, SKIN AND LEUKOCYTES

      Naunyn-Schmiedeberg's archives of pharmacology
    52. EICHELBAUM M
      THE ENANTIOMER VERSUS RACEMATE DEBATE - A CLINICAL PERSPECTIVE

      Naunyn-Schmiedeberg's archives of pharmacology
    53. SIEGLE I; FRITZ P; EICHELBAUM M; ZANGER UM
      DISTRIBUTION OF CYP2D6 MESSENGER-RNA AND PROTEIN IN EXTRAHEPATIC HUMAN TISSUES - A STUDY BY IN-SITU HYBRIDIZATION AND IMMUNOHISTOCHEMISTRY

      Naunyn-Schmiedeberg's archives of pharmacology
    54. GREINER B; VONRICHTER O; FRITZ P; ZUNDLER J; KREICHGAUER HP; KROEMER HK; EICHELBAUM M
      PHARMACOKINETIC INTERACTION BETWEEN DIGOXIN AND RIFAMPIN - THE ROLE OF P-GLYCOPROTEIN

      Naunyn-Schmiedeberg's archives of pharmacology
    55. GREINER B; VONRICHTER O; FRITZ P; ZUNDLER J; KREICHGAUER HP; KROEMER HK; EICHELBAUM M
      THE FATE OF NARINGIN, OF COUMARIN, AND OF NARINGIN PLUS COUMARIN IN MAN - WHERE OCCUR INTERACTIONS

      Naunyn-Schmiedeberg's archives of pharmacology
    56. SCHANZLE G; LI S; FROMM MF; ECKHARDT K; HOFMANN U; MIKUS G; EICHELBAUM M
      A RAPID, HIGHLY SENSITIVE HPLC MASS-SPECTROMETRIC METHOD FOR THE DETERMINATION OF MORPHINE AND ITS METABOLITES - APPLICATION TO PHARMACOKINETIC STUDIES

      Naunyn-Schmiedeberg's archives of pharmacology
    57. GREINER B; FRITZ P; ZUNDLER J; KREICHGAUER HP; KROEMER HK; EICHELBAUM M
      MARKED DECREASE OF DIGOXIN BIOAVAILABILITY BY RIFAMPIN

      Naunyn-Schmiedeberg's archives of pharmacology
    58. ECKERT S; MIKUS G; HOFMANN U; EICHELBAUM M
      PHARMACOKINETICS AND PHARMACODYNAMICS OF PLACEBO-CONTROLLED SINGLE RISING ORAL DOSES OF VERAPAMIL, S-VERAPAMIL AND R-VERAPAMIL

      Naunyn-Schmiedeberg's archives of pharmacology
    59. ETTL A; HOFMANN U; DAXER A; DIETRICH H; SCHMID E; EICHELBAUM M
      OCULAR PHARMACOKINETICS OF VERAPAMIL IN RABBITS

      Naunyn-Schmiedeberg's archives of pharmacology
    60. CHARI VV; CHRISTIANO LJ; EICHELBAUM M
      EXPECTATION TRAPS AND DISCRETION

      Journal of economic theory (Print)
    61. Darbar, D; Fromm, MF; Dell'Orto, S; Kim, RB; Kroemer, HK; Eichelbaum, M; Roden, DM
      Modulation by dietary salt of verapamil disposition in humans

      CIRCULATION
    62. EICHELBAUM M; VONBERGMANN K
      IN-MEMORIAM PROFESSOR DR. MED. DENGLER,HA NS,J

      Arzneimittel-Forschung
    63. BOHNENSTENGEL F; EICHELBAUM M; GOLBS E; KROEMER HK
      HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF ACROLEIN AS A MARKER FOR CYCLOPHOSPHAMIDE BIOACTIVATION IN HUMAN LIVER-MICROSOMES

      Journal of chromatography B. Biomedical sciences and applications
    64. BUSSE D; BUSCH FW; BOHNENSTENGEL F; EICHELBAUM M; FISCHER P; OPALINSKA J; SCHUMACHER K; SCHWEIZER E; KROEMER HK
      DOSE-ESCALATION OF CYCLOPHOSPHAMIDE IN PATIENTS WITH BREAST-CANCER - CONSEQUENCES FOR PHARMACOKINETICS AND METABOLISM

      Journal of clinical oncology
    65. FROMM MF; ECKHARDT K; LI SX; SCHANZLE G; HOFMANN U; MIKUS G; EICHELBAUM M
      LOSS OF ANALGESIC EFFECT OF MORPHINE DUE COADMINISTRATION OF RIFAMPIN

      Pain
    66. FROMM MF; KROEMER HK; EICHELBAUM M
      IMPACT OF P450 GENETIC-POLYMORPHISM ON THE FIRST-PASS EXTRACTION OF CARDIOVASCULAR AND NEUROACTIVE DRUGS

      Advanced drug delivery reviews
    67. EICHELBAUM M
      CONSEQUENCES OF POLYMORPHIC DRUG-METABOLISM FOR DRUG TOXICITY

      Naunyn-Schmiedeberg's archives of pharmacology
    68. ECKHARDT K; DILGER K; EICHELBAUM M; KUCHER K; MIKUS G
      CHRONOPHARMACOKINETIC AND CHRONOPHARMACO-DYNAMIC INVESTIGATION OF A NEW VERAPAMIL MODIFIED RELEASE FORMULATION

      Naunyn-Schmiedeberg's archives of pharmacology
    69. MORIKE K; SCHWAB M; MIKUS G; BOSEN N; EICHELBAUM M
      A DRUG-THERAPY INFORMATION-SERVICE FOR PRACTITIONERS IN NORTHERN WURTTEMBERG - FIRST EXPERIENCES WITH A HOTLINE

      Naunyn-Schmiedeberg's archives of pharmacology
    70. BUSSE D; BUSCH FW; BOHNENSTENGEL F; EICHELBAUM M; FISCHER P; SCHUMACHER K; SCHWEIZER E; KROEMER HK
      DIFFERENT APPLICATION SCHEDULES OF HIGH-DOSE CYCLOPHOSPHAMIDE - INFLUENCE ON KINETICS AND METABOLISM

      Naunyn-Schmiedeberg's archives of pharmacology
    71. ZANGER UM; FRITZ P; BEHRLE E; FRIEDEL A; KIVISTO K; EICHELBAUM M
      IMMUNOHISTOCHEMICAL ASSESSMENT OF CYP2D6 EXPRESSION IN NORMAL HUMAN TISSUE

      Naunyn-Schmiedeberg's archives of pharmacology
    72. GRIESE EU; GAEDIGK A; MORIKE; MIKUS G; ZANGER U; EICHELBAUM M
      CATALYTIC IN-VIVO FUNCTION OF CYP2D6 IN RELATION TO THE GENOTYPE

      Naunyn-Schmiedeberg's archives of pharmacology
    73. BOHNENSTENGEL F; BUSSE D; EICHELBAUM M; KROEMER HK
      BIOACTIVATION OF CYCLOPHOSPHAMIDE IN HUMAN LIVER-MICROSOMES - PREDICTIVE VALUE OF IN-VITRO DATA

      Naunyn-Schmiedeberg's archives of pharmacology
    74. STENGELE E; HINDER M; TRENK D; MULLERPELTZER H; EICHELBAUM M; JAHNCHEN E
      NONINVASIVE DETERMINATION OF CARDIODEPRESSANT EFFECTS OF PROPAFENONE BY IMPEDANCE CARDIOGRAPHY

      Naunyn-Schmiedeberg's archives of pharmacology
    75. SIEGLE I; KLEIN T; NUSING RM; FRITZ P; EICHELBAUM M
      EXPRESSION OF CYCLOOXYGENASE-1 AND CYCLOOXYGENASE-2 IN SYNOVIAL TISSUES OF PATIENTS WITH CHRONIC INFLAMMATORY AND DEGENERATIVE JOINT DISEASES

      Naunyn-Schmiedeberg's archives of pharmacology
    76. EVERT B; EICHELBAUM M; HAUBRUCK H; ZANGER UM
      FUNCTIONAL-PROPERTIES OF CYP2D6-1 (WILD-TYPE) AND CYP2D6-7 (HIS(324)PRO) EXPRESSED BY RECOMBINANT BACULOVIRUS IN INSECT CELLS

      Naunyn-Schmiedeberg's archives of pharmacology
    77. GROSS AS; MIKUS G; RATGE D; WISSER H; EICHELBAUM M
      PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ENANTIOMERS OF GALLOPAMIL

      The Journal of pharmacology and experimental therapeutics
    78. MIKUS G; TRAUSCH B; RODEWALD C; HOFMANN U; RICHTER K; GRAMATTE T; EICHELBAUM M
      EFFECT OF CODEINE ON GASTROINTESTINAL MOTILITY IN RELATION TO CYP2D6 PHENOTYPE

      Clinical pharmacology and therapeutics
    79. SPERKER B; MURDTER TE; FRITZ P; LINDER A; FRIEDEL G; BOSSLET K; EICHELBAUM M; KROEMER HK
      BIOACTIVATION OF A DOXORUBICIN GLUCURONIDE PRODRUG IN HUMAN LUNG AND BRONCHIAL-CARCINOMA - ROLE OF ELEVATED BETA-GLUCURONIDASE ACTIVITY

      Clinical pharmacology and therapeutics
    80. KROMER HK; BUSCH FW; BOHNENSTENGEL F; EICHELBAUM M; FISCHER P; OPALINSKA J; SCHUMACHER K; SCHWEIZER E; BUSSE D
      DOSE-ESCALATION OF CYCLOPHOSPHAMIDE IN PATIENTS WITH BREAST-CANCER - CONSEQUENCES FOR PHARMACOKINETICS AND METABOLISM

      Clinical pharmacology and therapeutics
    81. STUVEN T; GRIESE EU; KROEMER HK; EICHELBAUM M; ZANGER UM
      RAPID DETECTION OF CYP2D6 NULL ALLELES BY LONG DISTANCE-POLYMERASE AND MULTIPLEX-POLYMERASE CHAIN-REACTION

      Pharmacogenetics
    82. DALY AK; BROCKMOLLER J; BROLY F; EICHELBAUM M; EVANS WE; GONZALEZ FJ; HUANG JD; IDLE JR; INGELMANSUNDBERG M; ISHIZAKI T; JACQZAIGRAIN E; MEYER UA; NEBERT DW; STEEN VM; WOLF CR; ZANGER UM
      NOMENCLATURE FOR HUMAN CYP2D6 ALLELES

      Pharmacogenetics
    83. MORIKE K; KOCH M; FRITZ P; URBAN W; EICHELBAUM M
      IDENTIFICATION OF N-2 AS A METABOLITE OF ACETYLHYDRAZINE IN THE RAT

      Archives of toxicology
    84. EICHELBAUM M; EVERT B
      INFLUENCE OF PHARMACOGENETICS ON DRUG DISPOSITION AND RESPONSE

      Clinical and experimental pharmacology and physiology
    85. FROMM MF; BUSSE D; KROEMER HK; EICHELBAUM M
      DIFFERENTIAL INDUCTION OF PREHEPATIC AND HEPATIC-METABOLISM OF VERAPAMIL BY RIFAMPIN

      Hepatology
    86. KROEMER HK; FROMM MF; EICHELBAUM M
      STEREOSELECTIVITY IN DRUG-METABOLISM AND ACTION - EFFECTS OF ENZYME-INHIBITION AND INDUCTION

      Therapeutic drug monitoring
    87. BOHNENSTENGEL F; HOFMANN U; EICHELBAUM M; KROEMER HK
      CHARACTERIZATION OF THE CYTOCHROME-P450 INVOLVED IN SIDE-CHAIN OXIDATION OF CYLOPHOSPHAMIDE IN HUMANS

      European Journal of Clinical Pharmacology
    88. ENGEL G; HOFMANN U; HEIDEMANN H; COSME J; EICHELBAUM M
      ANTIPYRINE AS A PROBE FOR HUMAN OXIDATIVE DRUG-METABOLISM - IDENTIFICATION OF THE CYTOCHROME-P450 ENZYMES CATALYZING 4-HYDROXYANTIPYRINE, 3-HYDROMETHYLANTIPYRINE, AND NORANTIPYRINE FORMATION

      Clinical pharmacology and therapeutics
    89. KEVORKIAN JP; MICHEL C; HOFMANN U; JACQZAIGRAIN E; KROEMER HK; PERALDI MN; EICHELBAUM M; JAILLON P; FUNCKBRENTANO C
      ASSESSMENT OF INDIVIDUAL CYP2D6 ACTIVITY IN EXTENSIVE METABOLIZERS WITH RENAL-FAILURE - COMPARISON OF SPARTEINE AND DEXTROMETHORPHAN

      Clinical pharmacology and therapeutics
    90. DARBAR D; DELLORTO S; FROMM MF; KROEMER HK; EICHELBAUM M; RODEN DM
      DIETARY SALT AS A MODULATOR OF CYP3A EXPRESSION

      Circulation
    91. MEYER UA; AMREIN R; BALANT LP; BERTILSSON L; EICHELBAUM M; GUENTERT TW; HENAUER S; JACKSON P; LAUX G; MIKKELSEN H; PECK C; POLLOCK BG; PRIEST R; SJOQVIST F; DELINISTULA A
      ANTIDEPRESSANTS AND DRUG-METABOLIZING-ENZYMES - EXPERT GROUP-REPORT

      Acta psychiatrica Scandinavica
    92. BOHNENSTENGEL F; JOHNSON S; HOFMANN U; EICHELBAUM M; KROEMER HK
      DIRECT GAS-CHROMATOGRAPHIC DETERMINATION OF DECHLOROETHYLCYCLOPHOSPHAMIDE FOLLOWING MICROSOMAL INCUBATION OF CYCLOPHOSPHAMIDE

      Journal of chromatography B. Biomedical applications
    93. ENGEL G; HOFMANN U; EICHELBAUM M
      HIGHLY SENSITIVE AND SPECIFIC GAS-CHROMATOGRAPHIC TANDEM MASS-SPECTROMETRIC METHOD FOR THE DETERMINATION OF TRACE AMOUNTS OF ANTIPYRINE METABOLITES IN BIOLOGICAL-MATERIAL

      Journal of chromatography B. Biomedical applications
    94. KIVISTO KT; KROEMER HK; EICHELBAUM M
      THE ROLE OF HUMAN CYTOCHROME-P450 ENZYMES IN THE METABOLISM OF ANTICANCER AGENTS - IMPLICATIONS FOR DRUG-INTERACTIONS

      British journal of clinical pharmacology
    95. BUSSE D; COSME J; BEAUNE P; KROEMER HK; EICHELBAUM M
      CYTOCHROMES OF THE P450 2C SUBFAMILY ARE THE MAJOR ENZYMES INVOLVED IN THE O-DEMETHYLATION OF VERAPAMIL IN HUMANS

      Naunyn-Schmiedeberg's archives of pharmacology
    96. EBNER T; MEESE CO; EICHELBAUM M
      MECHANISM OF CYTOCHROME-P450 2D6-CATALYZED SPARTEINE METABOLISM IN HUMANS

      Molecular pharmacology
    97. KROEMER HK; EICHELBAUM M
      ITS THE GENES, STUPID - MOLECULAR-BASES AND CLINICAL CONSEQUENCES OF GENETIC CYTOCHROME-P450 2D6 POLYMORPHISM

      Life sciences
    98. MIKUS G; MAST V; RATGE D; WISSER H; EICHELBAUM M
      STEREOSELECTIVITY IN CARDIOVASCULAR AND BIOCHEMICAL-ACTION OF CALCIUM-ANTAGONISTS - STUDIES WITH THE ENANTIOMERS OF THE DIHYDROPYRIDINE NITRENDIPINE

      Clinical pharmacology and therapeutics
    99. FIRKUSNY L; KROEMER HK; EICHELBAUM M
      IN-VITRO CHARACTERIZATION OF CYTOCHROME-P450 CATALYZED METABOLISM OF THE ANTIEMETIC TROPISETRON

      Biochemical pharmacology
    100. EVERT B; GRIESE EU; EICHELBAUM M
      CLONING AND SEQUENCING OF A NEW NONFUNCTIONAL CYP2D6 ALLELE - DELETION OF T-1795 IN EXON-3 GENERATES A PREMATURE STOP CODON

      Pharmacogenetics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/10/20 alle ore 16:06:14